Compare MBC & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MBC | LMRI |
|---|---|---|
| Founded | 1954 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | N/A | 2025 |
| Metric | MBC | LMRI |
|---|---|---|
| Price | $11.63 | $17.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $15.00 | ★ $22.67 |
| AVG Volume (30 Days) | ★ 1.3M | 978.1K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $2,757,800,000.00 | $1,003,375,000.00 |
| Revenue This Year | $0.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.96 | ★ N/A |
| Revenue Growth | ★ 1.77 | 1.38 |
| 52 Week Low | $9.33 | $15.81 |
| 52 Week High | $18.15 | $19.45 |
| Indicator | MBC | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 56.90 | N/A |
| Support Level | $10.91 | N/A |
| Resistance Level | $11.66 | N/A |
| Average True Range (ATR) | 0.32 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 72.78 | 0.00 |
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.